Standard
Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin. / Tolessa, T.; Gutniak, M.K.; Holst, J.J.; Efendic, S.; Hellstrom, P.M.
I:
J. Clin. Invest., Nr. 102, 1998, s. 764-774.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Tolessa, T, Gutniak, MK, Holst, JJ, Efendic, S & Hellstrom, PM 1998, 'Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin', J. Clin. Invest., nr. 102, s. 764-774.
APA
Tolessa, T., Gutniak, M. K., Holst, J. J., Efendic, S., & Hellstrom, P. M. (1998). Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin. J. Clin. Invest., (102), 764-774.
Vancouver
Tolessa T, Gutniak MK, Holst JJ, Efendic S, Hellstrom PM. Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin. J. Clin. Invest. 1998;(102):764-774.
Author
Tolessa, T. ; Gutniak, M.K. ; Holst, J.J. ; Efendic, S. ; Hellstrom, P.M. / Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin. I: J. Clin. Invest. 1998 ; Nr. 102. s. 764-774.
Bibtex
@article{d5aa2df074c911dbbee902004c4f4f50,
title = "Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin",
author = "T. Tolessa and M.K. Gutniak and J.J. Holst and S. Efendic and P.M. Hellstrom",
year = "1998",
language = "English",
pages = "764--774",
journal = "Zeitschrift fur klinische Medizin",
issn = "0014-2972",
publisher = "Wiley-Blackwell",
number = "102",
}
RIS
TY - JOUR
T1 - Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin
AU - Tolessa, T.
AU - Gutniak, M.K.
AU - Holst, J.J.
AU - Efendic, S.
AU - Hellstrom, P.M.
PY - 1998
Y1 - 1998
M3 - Journal article
SP - 764
EP - 774
JO - Zeitschrift fur klinische Medizin
JF - Zeitschrift fur klinische Medizin
SN - 0014-2972
IS - 102
ER -
